These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30279764)

  • 1. Ascending aortic dissection in a young patient using a synephrine-containing workout supplement.
    Doctorian T; Do B
    J Cardiol Cases; 2017 May; 15(5):150-152. PubMed ID: 30279764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC-UV-QDa analysis of Citrus aurantium-labelled pre-workout supplements suggest only a minority contain the plant extract.
    Koh AHW; Chess-Williams R; Lohning AE
    J Pharm Biomed Anal; 2021 Jan; 193():113746. PubMed ID: 33190081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racemic synephrine found in Citrus aurantium-listing pre-workout supplements suggests a non-plant-based origin.
    Koh AHW; Chess-Williams R; Lohning AE
    Drug Test Anal; 2021 Aug; 13(8):1569-1575. PubMed ID: 33834625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
    Stohs SJ
    Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Published Bitter Orange Extract and
    Stohs SJ; Ray SD
    J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
    [No Abstract]   [Full Text] [Related]  

  • 8. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
    Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
    Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
    Shara M; Stohs SJ; Mukattash TL
    Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
    Haaz S; Fontaine KR; Cutter G; Limdi N; Perumean-Chaney S; Allison DB
    Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
    Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
    J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Case Reports on Adverse Events Related to Pre-workout Supplements Containing Synephrine.
    de Jonge MLL; Kieviet LC; Sierts M; Egberink LB; van der Heyden MAG
    Cardiovasc Toxicol; 2023 Jan; 23(1):1-9. PubMed ID: 36639595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsupported conclusions in the article "Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female".
    Stohs SJ
    Korean J Intern Med; 2014 May; 29(3):388-92. PubMed ID: 24851076
    [No Abstract]   [Full Text] [Related]  

  • 18. The Safety and Efficacy of
    Koncz D; Tóth B; Bahar MA; Roza O; Csupor D
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
    Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
    Pellati F; Benvenuti S
    J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.